BioArctic AB (publ)

OM:BIOA B 株式レポート

時価総額:SEK 12.7b

BioArctic 過去の業績

過去 基準チェック /06

BioArctic's earnings have been declining at an average annual rate of -12.6%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 3.4% per year.

主要情報

-12.6%

収益成長率

-12.5%

EPS成長率

Biotechs 業界の成長0.7%
収益成長率3.4%
株主資本利益率-9.5%
ネット・マージン-29.5%
次回の業績アップデート14 Nov 2024

最近の業績更新

Recent updates

BioArctic AB (publ) (STO:BIOA B) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Sep 01
BioArctic AB (publ) (STO:BIOA B) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Need To Know: The Consensus Just Cut Its BioArctic AB (publ) (STO:BIOA B) Estimates For 2024

Aug 15
Need To Know: The Consensus Just Cut Its BioArctic AB (publ) (STO:BIOA B) Estimates For 2024

Revenues Tell The Story For BioArctic AB (publ) (STO:BIOA B)

Apr 13
Revenues Tell The Story For BioArctic AB (publ) (STO:BIOA B)

News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

Feb 19
News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

Feb 03
News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

Investors Interested In BioArctic AB (publ)'s (STO:BIOA B) Revenues

Dec 23
Investors Interested In BioArctic AB (publ)'s (STO:BIOA B) Revenues

With EPS Growth And More, BioArctic (STO:BIOA B) Makes An Interesting Case

Nov 12
With EPS Growth And More, BioArctic (STO:BIOA B) Makes An Interesting Case

BioArctic AB (publ) (STO:BIOA B) Analysts Are Way More Bearish Than They Used To Be

Jul 21
BioArctic AB (publ) (STO:BIOA B) Analysts Are Way More Bearish Than They Used To Be

Analysts Have Lowered Expectations For BioArctic AB (publ) (STO:BIOA B) After Its Latest Results

Jul 15
Analysts Have Lowered Expectations For BioArctic AB (publ) (STO:BIOA B) After Its Latest Results

New Forecasts: Here's What Analysts Think The Future Holds For BioArctic AB (publ) (STO:BIOA B)

Jul 07
New Forecasts: Here's What Analysts Think The Future Holds For BioArctic AB (publ) (STO:BIOA B)

Things Look Grim For BioArctic AB (publ) (STO:BIOA B) After Today's Downgrade

May 06
Things Look Grim For BioArctic AB (publ) (STO:BIOA B) After Today's Downgrade

Companies Like BioArctic (STO:BIOA B) Can Afford To Invest In Growth

Mar 13
Companies Like BioArctic (STO:BIOA B) Can Afford To Invest In Growth

Broker Revenue Forecasts For BioArctic AB (publ) (STO:BIOA B) Are Surging Higher

Nov 30
Broker Revenue Forecasts For BioArctic AB (publ) (STO:BIOA B) Are Surging Higher

We're Not Worried About BioArctic's (STO:BIOA B) Cash Burn

Sep 16
We're Not Worried About BioArctic's (STO:BIOA B) Cash Burn

We're Interested To See How BioArctic (STO:BIOA B) Uses Its Cash Hoard To Grow

Apr 04
We're Interested To See How BioArctic (STO:BIOA B) Uses Its Cash Hoard To Grow

We Think BioArctic (STO:BIOA B) Can Easily Afford To Drive Business Growth

Dec 05
We Think BioArctic (STO:BIOA B) Can Easily Afford To Drive Business Growth

収支内訳

BioArctic の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

OM:BIOA B 収益、費用、利益 ( )SEK Millions
日付収益収益G+A経費研究開発費
30 Jun 24299-8823258
31 Mar 24252-12225816
31 Dec 236162292510
30 Sep 2360725918888
30 Jun 2361727018288
31 Mar 2361932715147
31 Dec 22229-111490
30 Sep 22232281310
30 Jun 2218-1471100
31 Mar 2221-1351040
31 Dec 2126-120970
30 Sep 2130-114950
30 Jun 2137-97890
31 Mar 2134-101870
31 Dec 2065-69860
30 Sep 2084-72870
30 Jun 2093-60870
31 Mar 2025278940
31 Dec 1928388910
30 Sep 197794411010
30 Jun 198524751010
31 Mar 19729380910
31 Dec 18722382890
30 Sep 1825758780
30 Jun 1819732770
31 Mar 181942983-17
31 Dec 1715715690
30 Sep 17193785422
30 Jun 17160714131
31 Mar 17127641760
31 Dec 16106581654
31 Dec 15424638

質の高い収益: BIOA B is currently unprofitable.

利益率の向上: BIOA B is currently unprofitable.


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: BIOA B is unprofitable, and losses have increased over the past 5 years at a rate of 12.6% per year.

成長の加速: Unable to compare BIOA B's earnings growth over the past year to its 5-year average as it is currently unprofitable

収益対業界: BIOA B is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-20.8%).


株主資本利益率

高いROE: BIOA B has a negative Return on Equity (-9.5%), as it is currently unprofitable.


総資産利益率


使用総資本利益率


過去の好業績企業の発掘